CD274 and neoplasm: Keynote-028—Expanding on a more detailed analysis of the entire trial cohort (n = 475) it was found that T-cell-inflamed gene expression profiles (GEP), PD-L1 expression and/or tumor mutational burden was associated with a higher likelihood of response to therapy.